Guinness Asset Management LTD Abb Vie Inc. Transaction History

Guinness Asset Management LTD

$5.27 Billion
Q3 2024

A detailed history of Guinness Asset Management LTD transactions in Abb Vie Inc. stock. As of the latest transaction made, Guinness Asset Management LTD holds 1,159,779 shares of ABBV stock, worth $204 Million. This represents 4.35% of its overall portfolio holdings.

Number of Shares

1,159,779

Previous 1,109,044 4.57%

Holding current value

$204 Million

Previous $190 Million 20.4%

% of portfolio

4.35%

Previous 3.92%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$163.84 - $199.33 $8.31 Million - $10.1 Million	50,735 Added 4.57%	1,159,779 $229 Million
Q2 2024 Jul 11, 2024	SELL	$154.79 - $180.76 $20.8 Million - $24.3 Million	-134,532 Reduced 10.82%	1,109,044 $190 Million
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $2.76 Million - $3.15 Million	-17,274 Reduced 1.37%	1,243,576 $226 Million
Q4 2023 Feb 12, 2024	BUY	$137.6 - $154.97 $125,216 - $141,022	910 Added 0.07%	1,260,850 $195 Million
Q3 2023 Nov 06, 2023	BUY	$133.59 - $154.65 $43.8 Million - $50.7 Million	327,755 Added 35.16%	1,259,940 $188 Million
Q2 2023 Jul 24, 2023	BUY	$132.51 - $164.9 $10 Million - $12.5 Million	75,525 Added 8.82%	932,185 $126 Million
Q1 2023 Apr 10, 2023	BUY	$144.61 - $166.54 $12.2 Million - $14 Million	84,137 Added 10.89%	856,660 $137 Million
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $31.2 Million - $37.4 Million	-225,323 Reduced 22.58%	772,523 $125 Million
Q3 2022 Oct 24, 2022	BUY	$134.21 - $153.93 $28.2 Million - $32.3 Million	209,932 Added 26.64%	997,846 $134 Million
Q2 2022 Sep 06, 2022	BUY	$137.62 - $174.96 $10 Million - $12.7 Million	72,809 Added 10.18%	787,914 $121 Million
Q1 2022 Apr 13, 2022	BUY	$131.98 - $163.75 $3.54 Million - $4.4 Million	26,841 Added 3.9%	715,105 $116 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $11.1 Million - $14.1 Million	103,447 Added 17.69%	688,264 $93.2 Million
Q3 2021 Dec 07, 2021	BUY	$106.4 - $120.78 $10.4 Million - $11.8 Million	97,357 Added 19.97%	584,817 $73.1 Million
Q2 2021 Aug 03, 2021	BUY	$105.21 - $117.21 $133,616 - $148,856	1,270 Added 0.26%	487,460 $54.9 Million
Q1 2021 Apr 21, 2021	SELL	$102.3 - $112.62 $603,570 - $664,458	-5,900 Reduced 1.2%	486,190 $52.6 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $9.06 Million - $12.2 Million	112,540 Added 29.65%	492,090 $52.7 Million
Q3 2020 Oct 27, 2020	BUY	$85.91 - $100.83 $348,794 - $409,369	4,060 Added 1.08%	379,550 $33.2 Million
Q2 2020 Jul 28, 2020	SELL	$73.37 - $98.18 $4.14 Million - $5.54 Million	-56,400 Reduced 13.06%	375,490 $36.9 Million
Q1 2020 Apr 30, 2020	BUY	$64.5 - $97.79 $483,750 - $733,425	7,500 Added 1.77%	431,890 $32.9 Million
Q4 2019 Feb 04, 2020	BUY	$72.13 - $90.25 $1.46 Million - $1.83 Million	20,300 Added 5.02%	424,390 $37.6 Million
Q3 2019 Oct 28, 2019	BUY	$62.98 - $75.72 $7.06 Million - $8.48 Million	112,040 Added 38.36%	404,090 $30.6 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $4.72 Million - $6.03 Million	71,840 Added 32.62%	292,050 $21.2 Million
Q4 2018 Jan 28, 2019	BUY	$77.85 - $96.01 $4.27 Million - $5.27 Million	54,840 Added 33.16%	220,210 $20.3 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $1.75 Million - $1.95 Million	19,710 Added 13.53%	165,370 $15.6 Million
Q2 2018 Aug 16, 2018	BUY	$89.78 - $106.23 $2.69 Million - $3.18 Million	29,910 Added 25.84%	145,660 $13.5 Million
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $1.78 Million - $2.38 Million	-19,350 Reduced 14.32%	115,750 $11 Million
Q4 2017 Jan 29, 2018	BUY	$89.56 - $98.21 $12.1 Million - $13.3 Million	135,100	135,100 $13.1 Million

Others Institutions Holding ABBV

# of Institutions

3,850

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $311B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guinness Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Guinness Asset Management LTD with notifications on news.

Account

Guinness Asset Management LTD Abb Vie Inc. Transaction History